These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21555676)

  • 1. Limitations of analyses based on achieved blood pressure: lessons from the African American study of kidney disease and hypertension trial.
    Davis EM; Appel LJ; Wang X; Greene T; Astor BC; Rahman M; Toto R; Lipkowitz MS; Pogue VA; Wright JT;
    Hypertension; 2011 Jun; 57(6):1061-8. PubMed ID: 21555676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
    Wright JT; Bakris G; Greene T; Agodoa LY; Appel LJ; Charleston J; Cheek D; Douglas-Baltimore JG; Gassman J; Glassock R; Hebert L; Jamerson K; Lewis J; Phillips RA; Toto RD; Middleton JP; Rostand SG;
    JAMA; 2002 Nov; 288(19):2421-31. PubMed ID: 12435255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood pressure control, drug therapy, and kidney disease.
    Contreras G; Greene T; Agodoa LY; Cheek D; Junco G; Dowie D; Lash J; Lipkowitz M; Miller ER; Ojo A; Sika M; Wilkening B; Toto RD;
    Hypertension; 2005 Jul; 46(1):44-50. PubMed ID: 15897360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed messages on blood pressure goals.
    Chobanian AV
    Hypertension; 2011 Jun; 57(6):1039-40. PubMed ID: 21555679
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful blood pressure control in the African American Study of Kidney Disease and Hypertension.
    Wright JT; Agodoa L; Contreras G; Greene T; Douglas JG; Lash J; Randall O; Rogers N; Smith MC; Massry S;
    Arch Intern Med; 2002 Jul; 162(14):1636-43. PubMed ID: 12123409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
    Agodoa LY; Appel L; Bakris GL; Beck G; Bourgoignie J; Briggs JP; Charleston J; Cheek D; Cleveland W; Douglas JG; Douglas M; Dowie D; Faulkner M; Gabriel A; Gassman J; Greene T; Hall Y; Hebert L; Hiremath L; Jamerson K; Johnson CJ; Kopple J; Kusek J; Lash J; Lea J; Lewis JB; Lipkowitz M; Massry S; Middleton J; Miller ER; Norris K; O'Connor D; Ojo A; Phillips RA; Pogue V; Rahman M; Randall OS; Rostand S; Schulman G; Smith W; Thornley-Brown D; Tisher CC; Toto RD; Wright JT; Xu S;
    JAMA; 2001 Jun; 285(21):2719-28. PubMed ID: 11386927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life in the African American Study of Kidney Disease and Hypertension: effects of blood pressure management.
    Lash JP; Wang X; Greene T; Gadegbeku CA; Hall Y; Jones K; Kusek JW; Sika M; Unruh M;
    Am J Kidney Dis; 2006 Jun; 47(6):956-64. PubMed ID: 16731290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons from the African-American Study of Kidney Disease and Hypertension: an update.
    Toto RD
    Curr Hypertens Rep; 2006 Oct; 8(5):409-12. PubMed ID: 16965728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.
    Juraschek SP; Appel LJ; Miller ER; Mukamal KJ; Lipsitz LA
    Hypertension; 2018 Oct; 72(4):986-993. PubMed ID: 30354704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of blood pressure control and antihypertensive drug regimen on glomerular filtration rate: the African-American Study of Kidney Disease and Hypertension Pilot Study.
    Hall WD; Kusek JW; Kirk KA; Appel LJ; Schulman G; Agodoa LY; Glassock R; Grim C; Randall OS; Massry SG
    Am J Kidney Dis; 1997 May; 29(5):720-8. PubMed ID: 9159306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
    Lea J; Greene T; Hebert L; Lipkowitz M; Massry S; Middleton J; Rostand SG; Miller E; Smith W; Bakris GL
    Arch Intern Med; 2005 Apr; 165(8):947-53. PubMed ID: 15851648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The African American Study of Kidney Disease and Hypertension (AASK) trial: what more have we learned?
    Sica DA
    J Clin Hypertens (Greenwich); 2003; 5(2):159-67. PubMed ID: 12671332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.
    Sarnak MJ; Greene T; Wang X; Beck G; Kusek JW; Collins AJ; Levey AS
    Ann Intern Med; 2005 Mar; 142(5):342-51. PubMed ID: 15738453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.
    Peterson JC; Adler S; Burkart JM; Greene T; Hebert LA; Hunsicker LG; King AJ; Klahr S; Massry SG; Seifter JL
    Ann Intern Med; 1995 Nov; 123(10):754-62. PubMed ID: 7574193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BP Reduction, Kidney Function Decline, and Cardiovascular Events in Patients without CKD.
    Magriço R; Bigotte Vieira M; Viegas Dias C; Leitão L; Neves JS
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):73-80. PubMed ID: 29101186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans.
    Appel LJ; Wright JT; Greene T; Kusek JW; Lewis JB; Wang X; Lipkowitz MS; Norris KC; Bakris GL; Rahman M; Contreras G; Rostand SG; Kopple JD; Gabbai FB; Schulman GI; Gassman JJ; Charleston J; Agodoa LY;
    Arch Intern Med; 2008 Apr; 168(8):832-9. PubMed ID: 18443258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality Outcomes With Intensive Blood Pressure Targets in Chronic Kidney Disease Patients.
    Aggarwal R; Petrie B; Bala W; Chiu N
    Hypertension; 2019 Jun; 73(6):1275-1282. PubMed ID: 31067189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group.
    Hebert LA; Kusek JW; Greene T; Agodoa LY; Jones CA; Levey AS; Breyer JA; Faubert P; Rolin HA; Wang SR
    Hypertension; 1997 Sep; 30(3 Pt 1):428-35. PubMed ID: 9314428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.